Seòmar agus comataidhean

International Fibromyalgia Day on 12 May 2024 is an important opportunity to raise awareness of this distressing and debilitating condition. We want to ensure that all people living with fibromyalgia in Scotland are able to access the best possible care and support. To mark its importance, on the 12 May 2024 the Scottish Government’s main building, St Andrew’s House, will be lit up in purple.

We are working hard to deliver the actions in our Pain management service delivery framework: implementation plan update to ensure everyone living with chronic pain, including fibromyalgia, can access the care and support they need to live well, on their own terms.

Scottish Ministers welcome the publication of the Competition and Markets Authority's completed investigation into the housing market, in particular those findings relating to Scotland and the published Scotland summary. We are considering their findings carefully and will respond formally in due course.

We also note the intention to investigate further issues relating to potential market information sharing and other matters. It is right that this is considered carefully and Ministers will consider this in turn when the Authority have completed their work on this issue.

(a) The Pain management - service delivery framework: implementation plan sets out the actions we will take to reduce the impact of chronic pain on quality of life and wellbeing and improve information, care and services for people in Scotland, which includes people living with chronic pain as a result of fibromyalgia. A report on the progress on the 18 initial actions was published on the 15 November 2023 Pain management service delivery implementation plan: progress report .

Additionally in November 2024, we published an updated Implementation Plan with updated actions following a period of stakeholder engagement. Progress on actions is discussed bi-monthly at the Pain Management Task Force , the minutes of which are available on the Scottish Government website.

We will continue to consult with people with lived experience of chronic pain, including those with fibromyalgia, throughout the development and delivery of actions outlined in the plan.

(b)The Short Life Working Groups (SLWGs) and Pain Management Networks established to support implementation of the Framework continue to evolve and develop the current actions. All the professional network leads (allied health professionals, pain psychologists, medics, pharmacist and nurses) are specialist pain management clinicians who have expert skills in supporting people with fibromyalgia.

Details on the role and membership of the Pain Management Task Force can be found at Pain Management Task Force .

Current guidelines for healthcare professionals regarding fibromyalgia are available from authoritative professional sources such as the Scottish Intercollegiate Guidelines Network (SIGN) - https://www.sign.ac.uk/our-guidelines/management-of-chronic-pain/ and the Royal College of Physicians https://www.rcplondon.ac.uk/guidelines-policy/diagnosis-fibromyalgia-syndrome

The National Pain Education Group is developing a Chronic Pain Toolkit for all health and social care staff across Scotland - it will be Scotland's first national chronic pain training resource. It will be hosted on TURAS on a dedicated page called The Chronic Pain Knowledge Hub. This has been developed with lived experience input and NHS Education for Scotland colleagues.

Local authorities take their own decisions about which digital tools, services and apps to deploy in their schools to support delivery of education. We expect that any digital service would be implemented in recognition of statutory duties arising from GDPR and Data Protection Act. As Data Controllers in their own right, it is for local authorities to ensure all digital services in schools comply with the relevant legislation.

Mycoplasma pneumonia infection typically is not severe but it can cause a pneumonia that is usually mild in nature. PHS has reviewed routine surveillance data available to them and are reassured that most presentations of mycoplasma pneumoniae infections are of a mild respiratory illness, with children most commonly presenting at GPs with common respiratory symptoms. To date, there have been no deaths in 1280 CARI patients positive for mycoplasma pneumoniae (up to week 7) within 28 days of their test.

The Scottish Government notes that PHS continues to encourage good hand and respiratory hygiene to help stop the spread of winter bugs, including mycoplasma pneumoniae. By keeping hands clean and helping to ensure children practice good respiratory hygiene, the spread of this infection can be reduced. The Scottish Government notes that information on managing the symptoms of common winter illnesses including self-help guides and advice on preventing onward transmission, can be found on NHS Inform. ( https://www.nhsinform.scot/winter-illness/ )

PHS has advised the Scottish Government that mycoplasma pneumoniae is a common cause of respiratory infections, particularly in school-aged children. Most infections display as a mild respiratory illness, however, some persons experience severe pneumonia and require hospitalization. Significant cyclical increases in mycoplasma pneumoniae infections are observed every 3–5 years, likely because of changes in the circulating strain.

Mycoplasma pneumoniae is one of many respiratory conditions to re-emerge following cessation of nonpharmaceutical interventions, including lockdowns and physical distancing, implemented as part of the pandemic response. After implementation of nonpharmaceutical interventions in response to COVID-19, the frequency of identified mycoplasma pneumoniae infections in Scotland substantially declined beginning in 2020, as was the case for other respiratory infections. Beginning in the autumn of 2023, the United States, China and other countries identified a re-emergence of the infection, a pattern similar to that observed in Scotland.

Since November 2021, sentinel surveillance data have been available for mycoplasma pneumoniae in Scotland through the CARI sentinel surveillance programme. In this programme, sentinel GP practices across Scotland recruit and swab patients with symptoms of acute respiratory infection. These samples are all tested for ten respiratory pathogens, including mycoplasma pneumoniae. Enhanced surveillance data, primarily relating to symptoms, are collected by an online questionnaire from patients tested in the programme. Analyses from these data suggest that most infections display as a mild respiratory illness. To date, there have been no deaths in 1280 CARI patients positive for mycoplasma pneumoniae (up to week 7) within 28 days of their test. With the information from CARI, GP providers have been advised that they should consider mycoplasma pneumoniae as part of the differential diagnosis for community-acquired pneumonia cases.

PHS separately analyses data on all microbiology laboratory specimen results across Scotland to identify positive mycoplasma pneumoniae test in hospitals or care homes, or as requested in the community (by GPs). These data are reviewed by PHS and NHS Health Boards to identify any clusters or trends resulting in severe disease that warrant further intervention. To date, no unusual outbreaks or evidence of increased severity of disease has been noted and public health guidance on management of cases/clinical treatment remains unchanged.

The Scottish Government recognises that surveillance is a critical part of our approach to monitoring and managing the spread and prevalence of mycoplasma pneumoniae, Covid-19 and other respiratory infections. Public Health Scotland (PHS) are responsible for delivering Scotland’s National Respiratory Surveillance Plan with the support of the Scottish Government.

As part of PHS’s work, respiratory infection levels, including those of mycoplasma pneumoniae, and their impact are closely monitored throughout the year using various sources of data, including microbiological sampling and laboratory test results from community and hospital settings, NHS 24 calls, primary care consultations, hospital admissions, and mortality by cause. Intelligence generated from the different Scottish surveillance systems, including for mycoplasma pneumoniae, are used to inform proactive measures to prevent spread and ensure timely clinical response.